These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7881194)

  • 61. Mathematical approaches to optimization of cancer chemotherapy.
    Zietz S; Nicolini C
    Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827
    [No Abstract]   [Full Text] [Related]  

  • 62. [Significance of the cell cycle for the effect of antineoplastic chemotherapy].
    Matthias M
    Acta Histochem Suppl; 1983; 27():95-104. PubMed ID: 6408710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs.
    Schabel FM; Simpson-Herren L
    Antibiot Chemother (1971); 1978; 23():113-27. PubMed ID: 348072
    [No Abstract]   [Full Text] [Related]  

  • 64. Introduction to resistance to anticancer agents.
    Kruh GD
    Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical application of the clonogenic assay.
    Kern DH; Bertelsen CA; Mann BD; Campbell MA; Morton DL; Cochran AJ
    Ann Clin Lab Sci; 1983; 13(1):10-5. PubMed ID: 6838146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A stem cell model of human tumor growth: implications for tumor cell clonogenic assays.
    Mackillop WJ; Ciampi A; Till JE; Buick RN
    J Natl Cancer Inst; 1983 Jan; 70(1):9-16. PubMed ID: 6571928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Recent aspects of the chemotherapy of malignant tumors (author's transl)].
    Hartenstein R
    MMW Munch Med Wochenschr; 1978 Sep; 120(35):1127-32. PubMed ID: 308609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
    Frei E; Richardson P; Avigan D; Bunnell C; Wheeler C; Elias A
    Bone Marrow Transplant; 1999 Nov; 24(9):939-45. PubMed ID: 10556951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The cell cycle and its significance for cancer treatment.
    Hill BT; Baserga R
    Cancer Treat Rev; 1975 Sep; 2(3):159-75. PubMed ID: 1104161
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical aspects of drug resistance.
    Holland JF
    Antibiot Chemother (1971); 1978; 23():238-46. PubMed ID: 348082
    [No Abstract]   [Full Text] [Related]  

  • 71. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy.
    Hill BT
    Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475
    [No Abstract]   [Full Text] [Related]  

  • 72. Cellular effects of cancer chemotherapy administration.
    Moran P
    J Intraven Nurs; 2000; 23(1):44-51. PubMed ID: 11013533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A hybrid cellular automaton model of solid tumor growth and bioreductive drug transport.
    Kazmi N; Hossain MA; Phillips RM
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1595-606. PubMed ID: 23221082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor cell kinetics and cancer chemotherapy.
    Toal DR
    Crit Care Update; 1981 Sep; 8(9):34-7. PubMed ID: 6912803
    [No Abstract]   [Full Text] [Related]  

  • 75. Application of metabolic-control logic to the requirements for cell division.
    Newsholme EA
    Biochem Soc Trans; 1990 Feb; 18(1):78-80. PubMed ID: 2185096
    [No Abstract]   [Full Text] [Related]  

  • 76. Sensitivity of latent cancer to chemotherapy.
    Schrek R
    Med Hypotheses; 1992 Jul; 38(3):215-6. PubMed ID: 1513276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumour resistance to cisplatin: a modelling approach.
    Marcu L; Bezak E; Olver I; van Doorn T
    Phys Med Biol; 2005 Jan; 50(1):93-102. PubMed ID: 15715425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.
    Cho H; Levy D
    Bull Math Biol; 2017 Dec; 79(12):2986-3012. PubMed ID: 29022203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estimation of tumor cell kill from Gompertz growth curves.
    Lloyd HH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):267-77. PubMed ID: 1149006
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.
    Dai Q; Ling YH; Lia M; Zou YY; Kroog G; Iwata KK; Perez-Soler R
    Clin Cancer Res; 2005 Feb; 11(4):1572-8. PubMed ID: 15746062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.